Literature DB >> 3816576

Postmarketing drug research and development.

R J Townsend.   

Abstract

Mesh：

Year:  1987        PMID： 3816576     DOI： 10.1177/10600280870211p216

Source DB:  PubMed          Journal:  Drug Intell Clin Pharm        ISSN： 0012-6578


× No keyword cloud information.
  8 in total

Review 1.  Drug utilisation studies as tools in health economics.

Authors:  J A Sacristán; J Soto
Journal:  Pharmacoeconomics       Date:  1994-04       Impact factor: 4.981

2.  Strategic use of pharmacoeconomic research in early drug development and global pricing.

Authors:  K Clemens; L P Garrison; A Jones; F Macdonald
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

Review 3.  Pharmacoeconomics and therapeutic drug monitoring.

Authors:  J L Bootman; D L Harrison
Journal:  Pharm World Sci       Date:  1997-08

4.  A pharmacoeconomic analysis of patients with symptoms of benign prostatic hyperplasia.

Authors:  P C Cockrum; S F Finder; A J Ries; R P Potyk
Journal:  Pharmacoeconomics       Date:  1997-06       Impact factor: 4.981

Review 5.  NSAIDs and the elderly. Toxicity and economic implications.

Authors:  A C Phillips; R P Polisson; L S Simon
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

6.  Pharmacoeconomic analysis in Saudi Arabia: an overdue agenda item for action.

Authors:  Abdulrazaq S Al-Jazairi; Nada S Al-Qadheeb; Aziza Ajlan
Journal:  Ann Saudi Med       Date:  2011 Jul-Aug       Impact factor: 1.526

Review 7.  Pharmacoeconomics guidelines: The need of hour for India.

Authors:  Sukhvinder Singh Oberoi; Avneet Oberoi
Journal:  Int J Pharm Investig       Date:  2014-07

Review 8.  Assessing the relationship between toxicity and economic cost of oncological target agents: A systematic review of clinical trials.

Authors:  Francesca Tartari; Alessandro Conti; Roy Cerqueti
Journal:  PLoS One       Date:  2017-08-22       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.